These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11251976)

  • 1. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells.
    Shin T; Nakayama T; Akutsu Y; Motohashi S; Shibata Y; Harada M; Kamada N; Shimizu C; Shimizu E; Saito T; Ochiai T; Taniguchi M
    Int J Cancer; 2001 Feb; 91(4):523-8. PubMed ID: 11251976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
    Cui J; Shin T; Kawano T; Sato H; Kondo E; Toura I; Kaneko Y; Koseki H; Kanno M; Taniguchi M
    Science; 1997 Nov; 278(5343):1623-6. PubMed ID: 9374462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
    Toura I; Kawano T; Akutsu Y; Nakayama T; Ochiai T; Taniguchi M
    J Immunol; 1999 Sep; 163(5):2387-91. PubMed ID: 10452972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
    Cui J; Watanabe N; Kawano T; Yamashita M; Kamata T; Shimizu C; Kimura M; Shimizu E; Koike J; Koseki H; Tanaka Y; Taniguchi M; Nakayama T
    J Exp Med; 1999 Sep; 190(6):783-92. PubMed ID: 10499917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.
    Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP
    J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.
    Trobonjaca Z; Kröger A; Stober D; Leithäuser F; Möller P; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2002 Apr; 168(8):3763-70. PubMed ID: 11937527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Sato H; Kondo E; Harada M; Koseki H; Nakayama T; Tanaka Y; Taniguchi M
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5690-3. PubMed ID: 9576945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis.
    Kaneko Y; Harada M; Kawano T; Yamashita M; Shibata Y; Gejyo F; Nakayama T; Taniguchi M
    J Exp Med; 2000 Jan; 191(1):105-14. PubMed ID: 10620609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
    Dieli F; Taniguchi M; Kronenberg M; Sidobre S; Ivanyi J; Fattorini L; Iona E; Orefici G; De Leo G; Russo D; Caccamo N; Sireci G; Di Sano C; Salerno A
    J Immunol; 2003 Aug; 171(4):1961-8. PubMed ID: 12902499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation.
    Nakayama T; Yamashita M; Kawano T; Shimizu C; Shibata Y; Kamata T; Kaneko Y; Kobayashi S; Takeda U; Motohashi S; Cui J; Taniguchi M
    Int Arch Allergy Immunol; 2001; 124(1-3):38-42. PubMed ID: 11306921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
    Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
    Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.